Medical Treatment of Pulmonary Arterial Hypertension Medical Treatment of Pulmonary Arterial Hypertension

Get up-to-date on the latest treatment strategies for pulmonary arterial hypertension.Seminars in Respiratory and Critical Care Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Related Links:

Conclusions: Our review revealed the low use of evidence-based practices for acute stroke care in LMIC. The true use in hospitals that do not conduct this research is probably even lower. Strategies to evaluate and improve health system performance for acute stroke care, including implantation of stroke units and making thrombolysis more available and affordable are needed in LMIC. Registration in Prospero: CRD42017069325.Neuroepidemiology 2018;51:104 –112
Source: Neuroepidemiology - Category: Epidemiology Source Type: research
Source: Jornal Brasileiro de Pneumologia - Category: Respiratory Medicine Source Type: research
Authors: Kosinski LR, Gil JA, Durand WM, DeFroda SF, Owens BD, Daniels AH Abstract OBJECTIVES: The purpose of this study is to identify patient characteristics that increase risk for unplanned readmission within 30 days of an initial hospital stay after outpatient rotator cuff repair (RCR). METHODS: A retrospective cohort study was performed utilizing the National Surgical Quality Improvement Program (ACS NSQIP) datasets from 2012-2015. Patients were preliminarily included in the study based on the presence of a primary Common Procedural Terminology (CPT) code for rotator cuff repair (23410, 23412, 23420, and 2...
Source: The Physician and Sportsmedicine Online - Category: Sports Medicine Tags: Phys Sportsmed Source Type: research
Condition:   Pulmonary Hypertension Interventions:   Other: Assessment at Low Altitude (470m above sea level);   Other: Exposure to High Altitude (2500m above sea level) Sponsor:   University of Zurich Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Pulmonary Hypertension Interventions:   Other: Low altitude: 470m above sea level;   Other: Säntis; 2500m above sea Level Sponsor:   University of Zurich Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Pulmonary Hypertension Interventions:   Other: Assessment at Low Altitude (470m above sea level);   Other: Exposure to High Altitude (2500m above sea level) Sponsor:   University of Zurich Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Pulmonary Hypertension Interventions:   Device: Simulated Altitude: (FiO2: 15.1);   Device: Shamed Hypoxia (FiO2: 20.9) Sponsor:   University of Zurich Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Pulmonary Hypertension Interventions:   Device: Simulated Altitude (FiO2: 15.1%);   Device: Shamed Hypoxia (FiO2: 20.9) Sponsor:   University of Zurich Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Hypertension Interventions:   Drug: Dapagliflozin;   Drug: Placebo - Cap Sponsor:   University of Guadalajara Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Heart Failure;   Hypertension;   Diabetes Mellitus;   Stroke;   BPH;   Hyperlipidemia Intervention:   Other: Virtual Visit Sponsor:   Brigham and Women's Hospital Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Health | Hypertension | Respiratory Medicine